Vaccine Production & Manufacturing
|Event Date/Time: Jun 28, 2010||End Date/Time: Jun 30, 2010|
Key areas being focussed on include;
Key advances in expression platforms and cell line developments
Optimisation of downstream protocols â€“ examining aspects of recovery, isolation and purification of complex vaccine products
Utilisation of flexible single-use disposables to deal with rapid capacity fluctuations, multi-product plant diversity and the ever increasing demands of the vaccine manufacturer.
Assessment of bioanalytical criteria during vaccine manufacture â€“ practical implications for the characterisation of complex vaccine products
Development of in vitro and in vivo potency assays for vaccine bioactivity
Meet vaccine leaders and scientists from big pharma and large biotechs, and understand how they are using innovative new approaches to overcome the challenges to the production of vaccines.
You will leave the meeting with a variety of new ideas and contacts to take back to your research organisation.
The Biorbis Vaccine Production & Manufacturing meeting focuses on delivering practical value, accelerating progress in the vaccine sector and reducing the cost and time of production.
With vaccines delivering 30-40% of pharmaceutical revenues, the optimisation of processes to, not only improve the supply of vaccines to the market but also to decrease the time to first dose, is more important than ever. As fermentation reactors start hitting thousand litre capacities, percent increases in output have dramatic impact on profitability and timescales.
Stay up-to-date with the latest advancements in this high value sector to ensure that your production chain is capitalising on its true potential.